![]() | |
Clinical data | |
---|---|
Trade names | Optimine |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H22N2 |
Molar mass | 290.410 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Azatadine (Optimine) is a first-generation antihistamine and anticholinergic drug that was synthesized in 1963 by Schering-Plough, a former American pharmaceutical company.[1][2]
It was patented in 1967.[3] It has been succeeded by both loratadine and desloratadine.[4]: 53 and marketing approvals have been widely withdrawn.[5][6][7][8]: 290 [9]
| |
---|---|
Benzimidazoles (*) |
|
Diarylmethanes |
|
Ethylenediamines |
|
Tricyclics |
|
Others |
|
For topical use |
|
| |||||
---|---|---|---|---|---|
H1 |
| ||||
H2 |
| ||||
H3 |
| ||||
H4 |
| ||||
|
| |
---|---|
Classes |
|
Antidepressants (Tricyclic antidepressants (TCAs)) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants |
|
Anticholinergics |
|
Others |
|
![]() | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |